SPONSOR
Kind Pharmaceuticals LLC
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 1
Kind Pharmaceuticals LLC is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Myelodysplastic Syndromes, Advanced or Metastatic Breast Cancer.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Kind Pharmaceuticals LLC
How many clinical trials has Kind Pharmaceuticals LLC sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Kind Pharmaceuticals LLC, of which 2 are actively recruiting participants. These trials cover conditions including Myelodysplastic Syndromes, Advanced or Metastatic Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Kind Pharmaceuticals LLC research focus on?
Kind Pharmaceuticals LLC clinical trials span Myelodysplastic Syndromes, Advanced or Metastatic Breast Cancer. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Kind Pharmaceuticals LLC clinical trial?
To participate in a Kind Pharmaceuticals LLC trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Kind Pharmaceuticals LLC trials with current recruitment status updated daily.
Clinical Trials by Kind Pharmaceuticals LLC
NCT06304103 Phase 2
Recruiting
A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome
Myelodysplastic Syndromes
NCT05187832 Phase 1
Recruiting
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
Advanced or Metastatic Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology